Search results
Results From The WOW.Com Content Network
Grapiprant is expeditiously absorbed and the reported serum concentration was reported to be 31.9 ng/ml in an amount of time of 1.5 hours. The actual body exposure to grapiprant after administration of one dose was shown to be 2000 ng·hr/mL. The degree and rate at which grapiprant is absorbed into the body, presents a mean bioavailability of 39%.
A study was made to see the effect of grapiprant, a prostaglandin EP4 receptor antagonist, which uses allosteric inhibition to prevent PGE 2 to bind to its receptor as opposed to generally blocking viable receptors such as prostaglandin endoperoxide synthase or cyclooxygenase. Studies have shown that grapiprant can be used to treat pain and ...
العربية; বাংলা; Bosanski; Català; Čeština; Ελληνικά; Español; Esperanto; Euskara; فارسی; Français; 한국어; Bahasa Indonesia ...
19224 Ensembl ENSG00000095303 ENSMUSG00000047250 UniProt P23219 P22437 RefSeq (mRNA) NM_000962 NM_001271164 NM_001271165 NM_001271166 NM_001271367 NM_001271368 NM_080591 NM_008969 RefSeq (protein) NP_000953 NP_001258093 NP_001258094 NP_001258095 NP_001258296 NP_001258297 NP_542158 NP_032995 Location (UCSC) Chr 9: 122.37 – 122.4 Mb Chr 2: 36.12 – 36.14 Mb PubMed search Wikidata View/Edit ...
This enzyme -related article is a stub. You can help Wikipedia by expanding it.
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more
What links here; Upload file; Special pages; Printable version; Page information; Get shortened URL; Download QR code
Fevipiprant (INN; code name QAW039) is a drug of the piprant class that was being developed by Novartis.It is a selective, orally available antagonist of the prostaglandin D 2 receptor 2 (DP 2 or CRTh2).